QVA149
Drug timelines are a Plus or Pro feature.
19 regulatory and trial events tracked for QVA149, covering 2012-11-22 to 2019-09-23. Get the full timeline:
Most recent: Clinical Trial Update: A Randomized, Multicenter, Open-label, Parallel-group, 12-week Study to Assess the Efficacy and Safety of Switching From Tiotropium to QVA149 (Indacaterol Maleate/Glycopyrronium Bromide) in Symptomatic Mild to Moderate COPD Patients [Phase 4]